Australia markets closed

Bio-Techne Corporation (TE1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
76.50+1.00 (+1.32%)
As of 09:18AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 12.15B
Enterprise value 12.47B
Trailing P/E 65.64
Forward P/E 38.91
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.45
Price/book (mrq)6.42
Enterprise value/revenue 11.74
Enterprise value/EBITDA 37.67

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-2.58%
S&P500 52-week change 326.49%
52-week high 380.50
52-week low 349.40
50-day moving average 365.71
200-day moving average 364.94

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5157.58M
Implied shares outstanding 6160.96M
Float 8155.83M
% held by insiders 10.97%
% held by institutions 1102.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.3
Forward annual dividend yield 40.39%
Trailing annual dividend rate 30.32
Trailing annual dividend yield 30.42%
5-year average dividend yield 40.44
Payout ratio 425.60%
Dividend date 3N/A
Ex-dividend date 410 May 2024
Last split factor 24:1
Last split date 330 Nov 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 17.59%
Operating margin (ttm)23.74%

Management effectiveness

Return on assets (ttm)6.11%
Return on equity (ttm)10.40%

Income statement

Revenue (ttm)1.15B
Revenue per share (ttm)7.32
Quarterly revenue growth (yoy)3.20%
Gross profit (ttm)N/A
EBITDA 326.3M
Net income avi to common (ttm)202.96M
Diluted EPS (ttm)1.15
Quarterly earnings growth (yoy)-30.10%

Balance sheet

Total cash (mrq)145.31M
Total cash per share (mrq)0.92
Total debt (mrq)494.73M
Total debt/equity (mrq)24.56%
Current ratio (mrq)4.08
Book value per share (mrq)12.78

Cash flow statement

Operating cash flow (ttm)306.88M
Levered free cash flow (ttm)192.58M